Cor Vasa 2021, 63(4):486-493 | DOI: 10.33678/cor.2021.041

(Cardiac troponins: current data on the diagnostic value and analytical characteristics of new determination methods)

Aleksey M. Chaulina, b, Dmitry V. Duplyakova, b
a Samarská regionální klinická kardiologická léčebna, Státní rozpočtový ústav zdravotní péče, Samara, Rusko
b Samarská státní lékařská univerzita, Federální státní rozpočtová vzdělávací instituce Ministerstva zdravotnictví Ruska, Samara, Rusko

The high levels of prevalence, morbidity, and mortality from cardiovascular diseases (CVDs) encourage researchers to conduct further research to find new biomarkers and improve methods of determining old biomarkers to optimize early diagnosis of CVDs. Relatively recently, new highly and ultrasensitive methods of cardiac troponin determination have been introduced into clinical practice, where the key advantage is the possibility of making an early optimal decision on the choice of further management tactics for patients admitted to the emergency department with chest pain. Currently, a considerable number of highly sensitive methods for determining cardiac troponins have been developed, which significantly differ in their qualitative characteristics. This article summarizes current information on the biology and diagnostic value of cardiac troponins and the analytical characteristics of highly sensitive determination methods.

Keywords: 99th percentil, Circadian features, Cardiac troponins, Cardiovascular diseases, Coefficient of variation

Received: January 19, 2021; Revised: March 26, 2021; Accepted: March 29, 2021; Published: August 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chaulin AM, Duplyakov DV. (Cardiac troponins: current data on the diagnostic value and analytical characteristics of new determination methods). Cor Vasa. 2021;63(4):486-493. doi: 10.33678/cor.2021.041.
Download citation

References

  1. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res 2017;113:1708-1718. Go to original source... Go to PubMed...
  2. Pasquale F, Syrris P, Kaski JP, et al. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ Cardiovasc Genet 2012; 5:10-17. Go to original source... Go to PubMed...
  3. Messner B, Baum H, Fischer P, et al. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol 2000;114:544-549. Go to original source...
  4. Ricchiutti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem 1999;45:2129-2135. Go to original source...
  5. Wens SCA, Schaaf GJ, Michels M, et al. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease. Circ Cardiovasc Genet 2016;9:6-13. Go to original source... Go to PubMed...
  6. Schmid J, Liesinger L, Birner-Gruenberger R, et al. Elevated cardiac troponin T in patients with skeletal myopathies. J Am Coll Cardiol 2018;71:1540-1549. Go to original source... Go to PubMed...
  7. Rusakov DY, Vologdina NN, Tulayeva ON. The development of striated cardiac muscle tissue in the walls of the caval and pulmonary veins. Journal of Anatomy and Histopathology 2015;4:105. (In Russian).
  8. Dhoot GK, Gell PG, Perry SV. The localization of the different forms of troponin I in skeletal and cardiac muscle cells. Exp Cell Res 1978;117:357-370. Go to original source... Go to PubMed...
  9. Dhoot GK, Perry SV. Distribution of polymorphic forms of troponin components and tropomyosin in skeletal muscle. Nature 1979;278:714-718. Go to original source... Go to PubMed...
  10. Filatov VL, Katruha AG, Bulargina TV. et al. Troponin: structure, properties and mechanism of functioning. Biochemistry 1999;64:1155-1174. (In Russ.).
  11. Velkov VV. The new international criteria of cardiac infarction and highly sensitive troponins: new possibilities and new problems. Klin Lab Diagn 2014;59:43-53. (In Russ.). Go to PubMed...
  12. Ni L, Wehrens XHT. Cardiac troponin I-more than a biomarker for myocardial ischemia? Ann Transl Med 2018;6:S17. Go to original source... Go to PubMed...
  13. Chaulin AM, Duplyakov DV. MicroRNAs in Atrial Fibrillation: Pathophysiological Aspects and Potential Biomarkers. Int J Biomed 2020;10:198-205. Go to original source...
  14. Chaulin AM, Abashina OE, Duplyakov DV. Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents. Russian Open Medical Journal 2020;9: e0305. Go to original source...
  15. Wilhelm J, Hettwer S, Schuermann M, et al. Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications. Clin Res Cardiol 2014;103:561-567. Go to original source... Go to PubMed...
  16. Dubin RF, Li Y, He J, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol 2013;14:229. Go to original source... Go to PubMed...
  17. Zumrutdal AO, Bakinen O, Ucan H, et al. Relationship between uremic myopathy and false-positive cardiac troponin T test. Nephron 2000;86:522-523. Go to original source... Go to PubMed...
  18. Klinkenberg LJJ, Wildi K, van der Linden N, et al. Diurnal rhythm of cardiac troponin: consequences for the diagnosis of acute myocardial infarction. Clin Chem 2016;62:1602-1611. Go to original source... Go to PubMed...
  19. Chaulin AM, Duplyakova PD, Duplyakov DV. Circadian rhythms of cardiac troponins: mechanisms and clinical significance. Russian Journal of Cardiology 2020;25:4061. (In Russ.) Go to original source...
  20. Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015;48:201-203. Go to original source... Go to PubMed...
  21. Shah A, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women. BMJ 2015;350:g7873. Go to original source... Go to PubMed...
  22. Gore MO, Seliger SL, deFilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014;63:1441-1448. Go to original source... Go to PubMed...
  23. Trupp RJ, Albert G, Ziegler A. Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits. Clin Biochem 2018;52:173. Go to original source... Go to PubMed...
  24. Venge P, Lindahl B. Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction. Clin Chem 2013;59:976-981. Go to original source... Go to PubMed...
  25. Aakre KM, Roraas T, Petersen PH, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem 2014;60:838-847. Go to original source... Go to PubMed...
  26. van der Linden N, Cornelis T, Klinkenberg LJJ, et al. Strong diurnal rhythm of troponin T, but not troponin I, in a patient with renal dysfunction. Int J Cardiol 2016;221:287-288. Go to original source... Go to PubMed...
  27. Zenina OYu, Makarova II, Ignatova YuP, et al. Chronophysiology and Chronopathology of Cardiovascular System (Literature Review). Ekologiya cheloveka [Human Ecology]. 2016;1:25-33. (In Russ.). Go to original source...
  28. Pervan P, Svaguša T, Prkačin I, et al. Urine high sensitive Troponin I measuring in patients with hypertension. Signa Vitae - A Journal In Intensive Care And Emergency Medicine 2017;13(Suppl. 3):62-64. Go to original source...
  29. Chaulin AM, Karslyan LS, Grigoriyeva EV, et al. Clinical and Diagnostic Value of Cardiac Markers in Human Biological Fluids. Kardiologiia 2019;59:66-75. (in Russ.) Go to original source... Go to PubMed...
  30. Mirzaii-Dizgah I, Riahi E. Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. Oral Diseases 2013;19:180-184. Go to original source... Go to PubMed...
  31. Chaulin AM, Duplyakova PD, Bikbaeva GR, et al. Concentration of high-sensitivity cardiac troponin I in the oral fluid in patients with acute myocardial infarction: a pilot study. Russian Journal of Cardiology 2020;25:3814. (In Russ.). Go to original source...
  32. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113(6):1333-1344. doi:10.1016/0002-8703(87)90645-4. Go to original source... Go to PubMed...
  33. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-393. Go to original source...
  34. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction [published correction appears in J Am Coll Cardiol 2001;37(3):973]. J Am Coll Cardiol 2000;36:959-969. Go to original source... Go to PubMed...
  35. Hermsen D, Apple F, Garcia-Beltràn L, et al. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab 2007;53:1-9. Go to PubMed...
  36. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-68. Go to original source... Go to PubMed...
  37. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-108. Go to original source... Go to PubMed...
  38. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-2693. Go to original source... Go to PubMed...
  39. Adams JE 3rd, Bodor GS, Dávila-Román VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-106. Go to original source... Go to PubMed...
  40. Apple FS. Counterpoint: Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012;58:169-171. Go to original source... Go to PubMed...
  41. International Federation of Clinical Chemistry and Laboratory Medicine: Task Force on Clinical Applications of Cardiac Bio-Markers. Analytical Characteristics of Commercial Cardiac Troponin I and T Assays Declared by the Manufacturer. International Federation of Clinical Chemistry and Laboratory Medicine. http://www.ifcc.org/media/477275/ifccenewsmay2018.pdf.
  42. Anand A, Shah ASV, Beshiri A, et al. Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction. Clin Chem 2019;65:484-489. Go to original source... Go to PubMed...
  43. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29(Suppl 1):S49-S52. Go to PubMed...
  44. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-1306. Go to original source... Go to PubMed...
  45. Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-225. Go to original source... Go to PubMed...
  46. Eggers KM, Apple FS, Lind L, et al. The applied statistical approach highly influences the 99th percentile of cardiac troponin I. Clin Biochem 2016;49:1109-1112. Go to original source... Go to PubMed...
  47. Cervellin G, Mattiuzzi C, Bovo C, et al. Diagnostic algorithms for acute coronary syndrome - is one better than another? Ann Transl Med 2016;4:193. Go to original source... Go to PubMed...
  48. Sörensen NA, Neumann JT, Ojeda F, et al. Challenging the 99th percentile: A lower troponin cutoff leads to low mortality of chest pain patients. Int J Cardiol 2017;232:289-293. Go to original source... Go to PubMed...
  49. Lippi G, Bonfanti L, Dipalo M, et al. Clinical, organizational and economic analysis of high-sensitivity cardiac troponin testing in the emergency department. Ann Res Hosp 2017;1:44. Go to original source...
  50. Pickering JW, Than MP, Cullen L, et al. Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis [published correction appears in Ann Intern Med 2017;167:528]. Ann Intern Med 2017;166:715-724. Go to original source... Go to PubMed...
  51. Ferencik M, Mayrhofer T, Lu MT, et al. High-sensitivity cardiac troponin I as a gatekeeper for coronary computed tomography angiography and stress testing in patients with acute chest pain. Clin Chem 2017;63:1724-1733. Go to original source... Go to PubMed...
  52. Jaeger C, Wildi K, Twerenbold R, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J 2016;171:92-102.e1025. Go to original source... Go to PubMed...
  53. Garcia-Osuna A, Gaze D, Grau-Agramunt M, et al. Ultrasensitive quantification of cardiac troponin I by a Single Molecule Counting method: analytical validation and biological features. Clin Chim Acta 2018;486:224-231. Go to original source... Go to PubMed...
  54. https://www.ifcc.org/media/478231/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v122019.pdf.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.